Kazuki Matsui - Concepedia

Author

Kazuki Matsui

Sumitomo Dainippon Pharma (Japan)ORCID

Also Known As

Chisato Nagata, K MATSUI, K Matsui, K. Matsui, K. Matsui R, Kazuki MATSUI, Kazuki Matsui

112

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Sumitomo Dainippon Pharma (Japan)Sumitomo Chemical (Japan)University of Michigan Kyoto University Mochida Pharmaceutical (Japan)

About

Kazuki Matsui is an author at Sumitomo Dainippon Pharma (Japan) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	26	764
2	Natural Sciences	4	4	117
3	Engineering	2	2	60
4	Health Sciences	1	1	23
5	Public Health	1	1	16

Kazuki Matsui

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib Yasuhiro Tsume, Susumu Takeuchi, Kazuki Matsui, European Journal of Pharmaceutical Sciences Pharmaceutical ScienceVitro Dissolution MethodologyWeak Base DrugMedicinePharmaceutical Technology	2015	82
Cerasome as an Infusible, Cell-Friendly, and Serum-Compatible Transfection Agent in a Viral Size Kazuki Matsui, Shinsuke Sando, Takashi Sera, Journal of the American Chemical Society	2006	81
IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis Tomomi Yamashita, Tomohiko Iwakura, Kazuki Matsui, Cardiovascular Research	2011	80
<i>In Vitro</i> Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting <i>in Vivo</i> Dissolution and Drug–Drug Interaction Caused by Acid-Reducing Agents Kazuki Matsui, Yasuhiro Tsume, Gregory E. Amidon, Molecular Pharmaceutics Pharmaceutical ScienceGastrointestinal SimulatorDrug–drug InteractionGastric PhGastrointestinal Pharmacology	2015	63
Discovery of a novel potent Na+/Ca2+ exchanger inhibitor: design, synthesis and structure–activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives Hirohiko Hasegawa, Masami Muraoka, Kazuki Matsui, Bioorganic & Medicinal Chemistry Letters	2003	57
The Evaluation of In Vitro Drug Dissolution of Commercially Available Oral Dosage Forms for Itraconazole in Gastrointestinal Simulator With Biorelevant Media Kazuki Matsui, Yasuhiro Tsume, Gregory E. Amidon, Journal of Pharmaceutical Sciences Pharmaceutical ScienceGastrointestinal SimulatorPharmacologyToxicologyPharmacotherapy	2016	56
The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS) Yasuhiro Tsume, Kazuki Matsui, Amanda L. Searls, European Journal of Pharmaceutical Sciences Pharmaceutical ScienceGastrointestinal SimulatorMedicineOral AbsorptionPharmacotherapy	2017	53
Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): An in vitro-in silico-in vivo approach Bart Hens, Marival Bermejo, Yasuhiro Tsume, European Journal of Pharmaceutical Sciences Bcs Class 2BOptimized SelectionGastrointestinal SimulatorMedicineGastroenterology	2018	53
Cerasome as an infusible and cell-friendly gene carrier: synthesis of cerasome-forming lipids and transfection using cerasome Yoshihiro Sasaki, Kazuki Matsui, Yasuhiro Aoyama, Nature Protocols Lipid PreparationBiosynthesisEngineeringBiochemistryMedicine	2006	48
Utilization of Gastrointestinal Simulator, an in Vivo Predictive Dissolution Methodology, Coupled with Computational Approach To Forecast Oral Absorption of Dipyridamole Kazuki Matsui, Yasuhiro Tsume, Susumu Takeuchi, Molecular Pharmaceutics	2017	36

Page 1